ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
18.16
Postura de Compra
17.80
Postura de Venta
18.98
Volume Operado de la Acción
53,737
18.20 Rango del Día 19.06
14.72 Rango de 52 semanas 25.20
Capitalización de Mercado [m]
Precio Anterior
18.78
Precio de Apertura
19.06
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
98,244
Acciones en circulación
112,499,205
Rendimiento del Dividendo
1.05%
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
-
turnover
658.06M
Beneficio neto
70.94M

Acerca de Carel Industries SpA

Sector
Air-cond,heating,refrig Eq
Industria
Air-cond,heating,refrig Eq
Sitio web
Sede
Padua, Padua, Ita
Fundado
-
Carel Industries SpA is listed in the Air-cond,heating,refrig Eq sector of the Italian Stock Exchange with ticker CRL. The last closing price for Carel Industries was 18.78 €. Over the last year, Carel Industries shares have traded in a share price range of 14.72 € to 25.20 €.

Carel Industries currently has 112,499,205 shares in issue. The market capitalisation of Carel Industries is 2.11 € billion.

CRL Últimas noticias

AGM Statement

RNS Number:5255T Creightons PLC 19 December 2003 Creightons plc ("the Company") All the resolutions put to shareholders today at the Annual General Meeting of the Company were duly...

Interim Results

RNS Number:2767T Creightons PLC 15 December 2003 CREIGHTONS plc ("the Group" or "the Company") Interim results for the six months ended 30 September 2003 Chairman's statement I am...

Directorate Change

RNS Number:0837Q Creightons PLC 23 September 2003 Creightons plc ("Creightons" or "the Company") Board Changes The Company announces that Bernard Johnson, Executive Director, has...

Final Results

RNS Number:9803N Creightons PLC 25 July 2003 CREIGHTONS PLC ("Creightons" or "the Company" or "the Group") Chairman's statement Review of the year This year has seen the...

Holding(s) in Company

RNS Number:2237N Creightons PLC 07 July 2003 Creightons Plc ("the Company") Holding in Company The Company was informed on 4 July 2003 that Nemisis Toiletries Limited (in...

Acquisition

RNS Number:8539J Creightons PLC 09 April 2003 Creightons plc ("Creightons", "the Company") Acquisition of Plant and Equipment Creightons is pleased to announce that it has...

Acquisition

RNS Number:4673I Creightons PLC 07 March 2003 Creightons plc ("Creightons", "the Company" or "the Group") Creightons is pleased to announce that it has agreed to acquire (through a...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.78-4.1182682154218.9419.8218.27977919.14683126DE
4-0.56-2.9914529914518.7219.8217.36974918.7449828DE
12-0.28-1.5184381778718.4420.0517.029824418.70759286DE
260.844.8498845265617.3220.0514.727922718.10830356DE
52-6.14-25.267489711924.325.214.727068218.9324855DE
156-7.49-29.200779727125.6528.614.724889721.05832187DE
2604.3631.594202898613.828.68.74914619.70175856DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WERFOLaboratorio Farmaceutico Erfo SPA
0.0319 €
(29.67%)
3k
NVPNVP Spa
3.80 €
(25.83%)
42.5k
MNLMonnalisa SPA
0.97 €
(19.75%)
62.92k
1GMEGamestop Corporation
30.00 €
(13.98%)
9.07k
ATONAton Green Storage Spa
2.72 €
(13.33%)
229k
1VIVVivendi SE
2.562 €
(-69.13%)
1.31k
GSRAAG Rent AA
0.0005 €
(-66.67%)
606.1k
EVAAAAskoll Eva AA
0.0002 €
(-50.00%)
4.44M
1PANWPalo Alto Networks Inc
196.14 €
(-46.93%)
55
WFTC26Finanzatech Spa
0.0157 €
(-28.31%)
750
TITTelecom Italia SpA
0.2734 €
(-0.51%)
908.69M
TITRTelecom Italia
0.3102 €
(-0.03%)
116.47M
ISPIntesa Sanpaolo Spa
3.8715 €
(-1.83%)
36.69M
ENELEnel Spa
6.944 €
(-1.07%)
31.78M
BPEBper Banca SPA
6.136 €
(-2.57%)
14.72M
JMoneyHoops JMoneyHoops 1 minuto hace
Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ
EATR
dstock07734 dstock07734 1 minuto hace
Yes
NWBO
KILLAZILLA KILLAZILLA 2 minutos hace
DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......
TLRY
gitreal gitreal 2 minutos hace
...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i
NBRI
flipper44 flipper44 3 minutos hace
Those people know we can still see them, right?
NWBO
awesomed007 awesomed007 3 minutos hace
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
awesomed007 awesomed007 3 minutos hace
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
Eatatjoes Eatatjoes 3 minutos hace
Paul Malec of Deer Park, NY
QOIL
fuagf fuagf 3 minutos hace
Yeps, yeps and yeps. Good ones.
NoMoDo NoMoDo 4 minutos hace
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.
HMBL
manibiotech manibiotech 4 minutos hace
Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you 
NWBO
1vman 1vman 4 minutos hace
*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔
UBQU
janice shell janice shell 5 minutos hace
First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so
HappyAlways HappyAlways 6 minutos hace
I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t
FNMA
TheDane TheDane 6 minutos hace
Not only did it hold but it’s on the way back up.
SMCI
OnTrack444 OnTrack444 6 minutos hace
Might see a dime after the RS!  

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!!  Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!!  GLTY
HMBL
manibiotech manibiotech 7 minutos hace
Interesting for sure but not conclusive which he repeat every day 

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience 


NWBO
FACT-MASTER FACT-MASTER 8 minutos hace
Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i
CDMO
arizona1 arizona1 9 minutos hace
Never trumpers are hilarious and brilliant too.
jimr1717 jimr1717 10 minutos hace
“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is
SINT
NoMoDo NoMoDo 11 minutos hace
If we don't see a dime, I will be shocked.
HMBL
Slyhunter Slyhunter 11 minutos hace
I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is
TSLA
nfrequent nfrequent 11 minutos hace
Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/
RNVA
XMaster2023 XMaster2023 11 minutos hace
Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will
NWBO

Su Consulta Reciente

Delayed Upgrade Clock